secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001193125-23-004111
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres Therapeutics posts corporate presentation at J.P. Morgan Conference; content not fully available
--------------------------------------------------------------------------------

- Filed updated corporate presentation as Exhibit 99.1 on January 9, 2023.
- Presentation dated January 2023 for 41st Annual J.P. Morgan Healthcare Conference.
- CEO Eric Shaff featured; specific pipeline or financial details not included in excerpt.
- No new material information can be confirmed from the limited exhibit text provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312523004111/0001193125-23-004111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312523004111/d439121d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-004111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer